The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer

  • Authors:
    • Luís S. Santos
    • Bruno C. Gomes
    • Rita Gouveia
    • Susana N. Silva
    • Ana  P. Azevedo
    • Vanessa Camacho
    • Isabel Manita
    • Octávia M. Gil
    • Teresa  C. Ferreira
    • Edward Limbert
    • José Rueff
    • Jorge F. Gaspar
  • View Affiliations

  • Published online on: August 27, 2013     https://doi.org/10.3892/or.2013.2702
  • Pages: 2458-2466
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Well-differentiated thyroid cancer (DTC) is the most common form of thyroid cancer (TC); however, with the exception of radiation exposure, its etiology remains largely unknown. Several single nucleotide polymorphisms (SNPs) have previously been implicated in DTC risk. Nucleotide excision repair (NER) polymorphisms, despite having been associated with cancer risk at other locations, have received little attention in the context of thyroid carcinogenesis. In order to evaluate the role of NER pathway SNPs in DTC susceptibility, we performed a case-control study in 106 Caucasian Portuguese DTC patients and 212 matched controls. rs2230641 (CCNH), rs2972388 (CDK7), rs1805329 (RAD23B), rs3212986 (ERCC1), rs1800067 (ERCC4), rs17655, rs2227869 (ERCC5), rs4253211 and rs2228529 (ERCC6) were genotyped using TaqMan® methodology, while conventional PCR-RFLP was employed for rs2228000 and rs2228001 (XPC). When considering all DTC cases, only rs2230641 (CCNH) was associated with DTC risk; a consistent increase in overall DTC risk was observed for both the heterozygous genotype (OR=1.89, 95% CI=1.14-3.14) and the variant allele carriers (OR=1.79, 95% CI=1.09-2.93). Histological stratification analysis confirmed an identical effect on follicular TC (OR=2.72, 95% CI=1.19-6.22, for heterozygous; OR=2.44, 95% CI=1.07‑5.55, for variant allele carriers). Considering papillary TC, the rs2228001 (XPC) variant genotype was associated with increased risk (OR=2.33, 95% CI=1.05-5.16), while a protective effect was observed for rs2227869 (ERCC5) (OR=0.26, 95% CI=0.08‑0.90, for heterozygous; OR=0.25, 95% CI=0.07-0.86, for variant allele carriers). No further significant results were observed. Our results suggest that NER polymorphisms such as rs2230641 (CCNH) and, possibly, rs2227869 (ERCC5) and rs2228001 (XPC), may influence DTC susceptibility. However, larger studies are required to confirm these results.
View References

Related Articles

Journal Cover

November 2013
Volume 30 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Santos LS, Gomes BC, Gouveia R, Silva SN, Azevedo AP, Camacho V, Manita I, Gil OM, Ferreira TC, Limbert E, Limbert E, et al: The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer. Oncol Rep 30: 2458-2466, 2013
APA
Santos, L.S., Gomes, B.C., Gouveia, R., Silva, S.N., Azevedo, A.P., Camacho, V. ... Gaspar, J.F. (2013). The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer. Oncology Reports, 30, 2458-2466. https://doi.org/10.3892/or.2013.2702
MLA
Santos, L. S., Gomes, B. C., Gouveia, R., Silva, S. N., Azevedo, A. P., Camacho, V., Manita, I., Gil, O. M., Ferreira, T. C., Limbert, E., Rueff, J., Gaspar, J. F."The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer". Oncology Reports 30.5 (2013): 2458-2466.
Chicago
Santos, L. S., Gomes, B. C., Gouveia, R., Silva, S. N., Azevedo, A. P., Camacho, V., Manita, I., Gil, O. M., Ferreira, T. C., Limbert, E., Rueff, J., Gaspar, J. F."The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer". Oncology Reports 30, no. 5 (2013): 2458-2466. https://doi.org/10.3892/or.2013.2702